Venous thromboembolism in patients with primary bone or soft-tissue sarcomas

Journal of Bone and Joint Surgery

Volumn 89, Issue 11, 2007, Pages 2433-2439

  Mitchell, Sheryl Y ^a   Lingard, Elizabeth A ^b   Kesteven, Patrick ^a   McCaskie, Andrew W ^b   Gerrand, Craig H ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CHEMOPROPHYLAXIS; CHONDROSARCOMA; DEEP VEIN THROMBOSIS; DEMOGRAPHY; EWING SARCOMA; FATALITY; FEMALE; HUMAN; INFORMATION PROCESSING; LEIOMYOSARCOMA; LIMB TUMOR; LIPOSARCOMA; LUNG EMBOLISM; LUNG VENTILATION PERFUSION RATIO; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MEDICAL RECORD REVIEW; ORTHOPEDIC SURGERY; OSTEOSARCOMA; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROTECTIVE CLOTHING; RADIODIAGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SOFT TISSUE SARCOMA; TRUNK; VENOUS THROMBOEMBOLISM;

EID: 36048982161     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.F.01308     Document Type: Article

References (13)

1. House of Commons Health Committee. The prevention of venous thromboembolism in hospitalised patients. Second Report of Session 2004-5. 2005 Feb 23. http://www.publications.parliament.uk/pa/cm200405/cmselect/cmhealth/99/ 9902.htm. Accessed 2005 November 27.
2. Peuscher FW. Thrombosis and bleeding in cancer patients. Neth J Med. 1981;24:23-35.
3. Clagett GP, Anderson FA, Geerts W, Heit JA, Knudson M, Lieberman JR, Merli GJ, Wheeler HB. Prevention of venous thromboembolism. Chest. 1998;114(5 Suppl):531S-60S.
4. Lin PP, Graham D, Hann LE, Boland PJ, Healey JH. Deep venous thrombosis after orthopaedic surgery in adult cancer patients. J Surg Oncol. 1998;68;41-7.
5. Scottish Intercollegiate Guidelines Network (SIGN). Prophylaxis of venous thromboembolism: a national clinical guideline. 2002 Oct. http://www.sign. ac.uk/pdf/sign62.pdf. Accessed 2005 May 4.
6. Proceedings of the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: evidence-based guidelines. Chest. 2004:126(3 Suppl):172S-696S.
7. Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A, Dietrich-Neto F; ENOXACAN II Investigators. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346:975-80.
8. Amirkhosravi A, Mousa SA, Amaya M, Francis JL. Antimetastatic effect of tinzaparin, a low-molecular-weight heparin. J Thromb Haemost. 2003;1:1972-6.
9. Salvati EA, Pellegrini VD, Sharrock NE, Lotke PA, Murray DW, Potter H, Westrich GH. Recent advances in venous thromboembolic prophylaxis during and after total hip replacement. J Bone Joint Surg Am. 2000;82:252-70.
10. Obuobie K, Roach H, Harvey J, Lazarus JH. An abnormal venous clot. Lancet. 2001;357:1334.
11. Kakkar AK, Levine M, Pinedo HM, Wolff R, Wong J. Venous thrombosis in cancer patients: insights from the FRONTLINE survey. Oncologist. 2003;8:381-8.
12. Geerts WH, Pinew GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004:126(3 Suppl):338S-400S.
13. Nieto JA, De Tuesta AD, Marchena PJ, Tiberio G, Todoli JA, Samperiz AL, Monreal M; Riete Investigators. Clinical outcome of patients with venous thromboembolism and recent major bleeding: findings from a prospective registry (RIETE). J Thromb Haemost. 2005;3:703-9.